What is the first-line antibiotic choice after intercourse for suspected sexually transmitted infections (STIs)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

First-Line Antibiotic Choice After Intercourse for Suspected STIs

For suspected sexually transmitted infections after intercourse, the first-line antibiotic regimen is ceftriaxone 125 mg IM in a single dose PLUS azithromycin 1 g orally in a single dose if chlamydial infection is not ruled out. 1

Rationale for Treatment

  • Dual therapy is recommended because coinfection with both gonorrhea and chlamydia is common in patients with STIs 1
  • This combination targets the two most common bacterial STIs: Neisseria gonorrhoeae and Chlamydia trachomatis 1
  • Single-dose therapy ensures virtually 100% compliance, which is crucial for effective treatment of STIs 2

Recommended First-Line Regimen

For suspected gonorrhea and chlamydia:

  • Ceftriaxone 125 mg IM in a single dose 1
    • Highly effective against uncomplicated gonococcal infections
    • Reliable cure rate >90% for gonococcal infections 1

PLUS (if chlamydial infection is not ruled out):

  • Azithromycin 1 g orally in a single dose 1
    • Equally efficacious to doxycycline for chlamydial infections 1
    • Provides single-dose, directly observed therapy 1
    • 96% cure rate for chlamydial infections 3

Alternative Regimens

If ceftriaxone is not available:

  • Ciprofloxacin 500 mg orally in a single dose (for gonorrhea) 1
  • Cefixime 400 mg orally plus azithromycin 1 g orally in a single dose 1

If azithromycin is not available:

  • Doxycycline 100 mg orally twice daily for 7 days (for chlamydia) 1

Special Considerations

Pregnancy

  • Pregnant women should not be treated with quinolones or tetracyclines 1
  • Recommended regimens for pregnant women:
    • Ceftriaxone 125 mg IM for gonorrhea 1
    • Azithromycin 1 g orally in a single dose or amoxicillin 500 mg orally three times a day for 7 days for chlamydia 1

Allergy Considerations

  • For patients who cannot tolerate cephalosporins or quinolones, spectinomycin can be used, but it's unreliable (only 52% effective) against pharyngeal infections 1

Adolescents

  • The same regimens can be used for adolescents who weigh >45 kg 1

Follow-Up Recommendations

  • Patients treated with recommended regimens do not need a test of cure 1
  • Patients should be instructed to abstain from sexual intercourse until therapy is completed and until they and their sex partners no longer have symptoms 1
  • Sex partners should be evaluated and treated if they had sexual contact with the patient within 60 days before onset of symptoms or diagnosis 1
  • Consider retesting approximately 3 months after treatment due to high rates of reinfection 1

Prophylaxis After Sexual Assault

For cases of sexual assault, a more comprehensive regimen is recommended:

  • Ceftriaxone 125 mg IM in a single dose, PLUS
  • Metronidazole 2 g orally in a single dose, PLUS
  • Azithromycin 1 g orally in a single dose or doxycycline 100 mg orally twice a day for 7 days 1

This approach is supported by evidence showing high acceptability (88%) of antibiotic prophylaxis among sexual assault victims and low follow-up rates (57% at two weeks, 30% at three months) 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Azithromycin in the treatment of sexually transmitted disease.

The Journal of antimicrobial chemotherapy, 1990

Research

Should we offer antibiotic prophylaxis post sexual assault?

International journal of STD & AIDS, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.